Processes for making modulators of cystic fibrosis transmembrane conductance regulator
US-12415798-B2 · Sep 16, 2025 · US
This page is not indexed by search engines while we improve data quality.
Studley John patents
Studley John is listed as an inventor on 40 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Studley John |
| Total patents | 40 |
| First publication | Feb 17, 2015 |
| Latest publication | Sep 16, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds useful as inhibitors of atr kinase
US-2025223292-A1 · Jul 10, 2025 · US
Compounds useful as inhibitors of ATR kinase
US-12187731-B2 · Jan 7, 2025 · US
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
US-2024025877-A1 · Jan 25, 2024 · US
Compounds useful as inhibitors of atr kinase
US-2023271963-A1 · Aug 31, 2023 · US
Compounds useful as inhibitors of ATR kinase
US-11485739-B2 · Nov 1, 2022 · US
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
US-11465985-B2 · Oct 11, 2022 · US
Processes for preparing pyrrolidine compounds
US-11434201-B2 · Sep 6, 2022 · US
Compounds useful as inhibitors of ATR kinase
US-11370798-B2 · Jun 28, 2022 · US
Compounds useful as inhibitors of ATR kinase
US-11117900-B2 · Sep 14, 2021 · US
Recent patents
Latest publications not already listed above.
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
US-2021246117-A1 · Aug 12, 2021 · US
Compounds useful as inhibitors of atr kinase
US-2021047333-A1 · Feb 18, 2021 · US
Compounds useful as inhibitors of atr kinase
US-2021032255-A1 · Feb 4, 2021 · US
Processes for preparing pyrrolidine compounds
US-2020369608-A1 · Nov 26, 2020 · US
Processes for preparing ATR inhibitors
US-10822331-B2 · Nov 3, 2020 · US
Compounds useful as inhibitors of ATR kinase
US-10815239-B2 · Oct 27, 2020 · US
Compounds useful as inhibitors of ATR kinase
US-10800781-B2 · Oct 13, 2020 · US
Compounds useful as inhibitors of ATR kinase
US-10787452-B2 · Sep 29, 2020 · US
Compounds useful as inhibitors of atr kinase
US-2020140441-A1 · May 7, 2020 · US
Compounds useful as inhibitors of ATR kinase
US-10392391-B2 · Aug 27, 2019 · US
Compounds useful as inhibitors of atr kinase
US-2019256516-A1 · Aug 22, 2019 · US
Processes for preparing atr inhibitors
US-2019202818-A1 · Jul 4, 2019 · US
Processes for preparing ATR inhibitors
US-10208027-B2 · Feb 19, 2019 · US
Compounds useful as inhibitors of atr kinase
US-2019010163-A1 · Jan 10, 2019 · US
Compounds useful as inhibitors of ATR kinase
US-10160760-B2 · Dec 25, 2018 · US
Compounds useful as inhibitors of ATR kinase
US-10093676-B2 · Oct 9, 2018 · US
Processes for preparing atr inhibitors
US-2018244662-A1 · Aug 30, 2018 · US
Compounds useful as inhibitors of atr kinase
US-2018072735-A1 · Mar 15, 2018 · US
Processes for making compounds useful as inhibitors of ATR kinase
US-9862709-B2 · Jan 9, 2018 · US
Compounds useful as inhibitors of atr kinase
US-2017349596-A1 · Dec 7, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Vertex Pharma | 40 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 34 |
| A61P43/00 | 30 |
| C07D487/04 | 26 |
| A61K31/519 | 26 |
| C07D401/04 | 16 |